145 related articles for article (PubMed ID: 27488299)
21. The Influence of Histologic Subtype in Predicting Survival of Lung Cancer Patients With Spinal Metastases.
Kumar N; Tan KA; Tan JH; Zaw AS; Hey HWD; Ruiz J; Stone E
Clin Spine Surg; 2018 Feb; 31(1):E1-E7. PubMed ID: 27875414
[TBL] [Abstract][Full Text] [Related]
22. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems.
Wibmer C; Leithner A; Hofmann G; Clar H; Kapitan M; Berghold A; Windhager R
Spine (Phila Pa 1976); 2011 Nov; 36(23):1977-86. PubMed ID: 21304424
[TBL] [Abstract][Full Text] [Related]
23. [Surgical management of vertebral column metastatic disease].
Schaser KD; Melcher I; Mittlmeier T; Schulz A; Seemann JH; Haas NP; Disch AC
Unfallchirurg; 2007 Feb; 110(2):137-59; quiz 160-1. PubMed ID: 17287967
[TBL] [Abstract][Full Text] [Related]
24. Surgical management of primary and metastatic spinal tumors.
Kaloostian PE; Zadnik PL; Etame AB; Vrionis FD; Gokaslan ZL; Sciubba DM
Cancer Control; 2014 Apr; 21(2):133-9. PubMed ID: 24667399
[TBL] [Abstract][Full Text] [Related]
25. Integrating Evidence-Based Medicine for Treatment of Spinal Metastases Into a Decision Framework: Neurologic, Oncologic, Mechanicals Stability, and Systemic Disease.
Barzilai O; Laufer I; Yamada Y; Higginson DS; Schmitt AM; Lis E; Bilsky MH
J Clin Oncol; 2017 Jul; 35(21):2419-2427. PubMed ID: 28640703
[TBL] [Abstract][Full Text] [Related]
26. New therapeutics in spine metastases.
Bilsky MH
Expert Rev Neurother; 2005 Nov; 5(6):831-40. PubMed ID: 16274340
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of prostate cancer metastatic to the spine.
Williams BJ; Fox BD; Sciubba DM; Suki D; Tu SM; Kuban D; Gokaslan ZL; Rhines LD; Rao G
J Neurosurg Spine; 2009 May; 10(5):414-22. PubMed ID: 19442002
[TBL] [Abstract][Full Text] [Related]
28. [Treating metastatic vertebral tumor with percutaneous vertebroplasty: a report of 28 cases].
Yang ZZ; Xu JB; Yuan T; Qian BS; Zhang JY; Li WZ; Li JL; Xiao YB; Peng M; Li Y; Luan L
Ai Zheng; 2005 Feb; 24(2):194-8. PubMed ID: 15694032
[TBL] [Abstract][Full Text] [Related]
29. Assessment of quality of life after surgery for spinal metastases: position statement of the Global Spine Tumour Study Group.
Choi D; Morris S; Crockard A; Albert T; Bunger C; Fehlings M; Harrop J; Kawahara N; Martin JA; Massicotte EM; Mazel C; Oner FC; Peul W; Tomita K; Wang M
World Neurosurg; 2013 Dec; 80(6):e175-9. PubMed ID: 23422266
[TBL] [Abstract][Full Text] [Related]
30. Surgical management of metastatic spinal tumors.
Laufer I; Sciubba DM; Madera M; Bydon A; Witham TJ; Gokaslan ZL; Wolinsky JP
Cancer Control; 2012 Apr; 19(2):122-8. PubMed ID: 22487974
[TBL] [Abstract][Full Text] [Related]
31. Emerging and established clinical, histopathological and molecular parametric prognostic factors for metastatic spine disease secondary to lung cancer: Helping surgeons make decisions.
Batista N; Tee J; Sciubba D; Sahgal A; Laufer I; Weber M; Gokaslan Z; Rhines L; Fehlings M; Patel S; Raja Rampersaud Y; Reynolds J; Chou D; Bettegowda C; Clarke M; Fisher C
J Clin Neurosci; 2016 Dec; 34():15-22. PubMed ID: 27634496
[TBL] [Abstract][Full Text] [Related]
32. Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection.
Sciubba DM; De la Garza Ramos R; Goodwin CR; Abu-Bonsrah N; Bydon A; Witham TF; Bettegowda C; Gokaslan ZL; Wolinsky JP
Neurosurg Focus; 2016 Aug; 41(2):E9. PubMed ID: 27476851
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with improved survival following surgical treatment for metastatic prostate cancer in the spine: retrospective analysis of 29 patients in a single center.
Meng T; Chen R; Zhong N; Fan T; Li B; Yin H; Li Z; Zhou W; Song D; Xiao J
World J Surg Oncol; 2016 Jul; 14(1):200. PubMed ID: 27472919
[TBL] [Abstract][Full Text] [Related]
34. Minimal access versus open spinal surgery in treating painful spine metastasis: a systematic review.
Yang Z; Yang Y; Zhang Y; Zhang Z; Chen Y; Shen Y; Han L; Xu D; Sun H
World J Surg Oncol; 2015 Feb; 13():68. PubMed ID: 25880538
[TBL] [Abstract][Full Text] [Related]
35. Hospital readmission rates after surgical treatment of primary and metastatic tumors of the spine.
Schairer WW; Carrer A; Sing DC; Chou D; Mummaneni PV; Hu SS; Berven SH; Burch S; Tay B; Deviren V; Ames C
Spine (Phila Pa 1976); 2014 Oct; 39(21):1801-8. PubMed ID: 25029220
[TBL] [Abstract][Full Text] [Related]
36. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis.
Tokuhashi Y; Matsuzaki H; Oda H; Oshima M; Ryu J
Spine (Phila Pa 1976); 2005 Oct; 30(19):2186-91. PubMed ID: 16205345
[TBL] [Abstract][Full Text] [Related]
37. Top Ten Tips Palliative Care Clinicians Should Know About Spinal Tumors.
Williamson T; Painter B; Howell EP; Goodwin CR
J Palliat Med; 2019 Jan; 22(1):84-89. PubMed ID: 30570435
[TBL] [Abstract][Full Text] [Related]
38. Survival rates of patients with metastatic spinal cancer after scintigraphic detection of abnormal radioactive accumulation.
Tatsui H; Onomura T; Morishita S; Oketa M; Inoue T
Spine (Phila Pa 1976); 1996 Sep; 21(18):2143-8. PubMed ID: 8893440
[TBL] [Abstract][Full Text] [Related]
39. Life Expectancy and Metastatic Spine Scoring Systems: An Academic Institutional Experience.
Ragel BT; Mendez GA; Reddington J; Ferachi D; Kubicky CD; Philipp TC; Zusman NL; Klimo P; Hart R; Yoo J; Ching AC
Clin Spine Surg; 2017 Oct; 30(8):335-342. PubMed ID: 28937454
[TBL] [Abstract][Full Text] [Related]
40. Metastatic tumors of the axial spine.
Perrin RG
Curr Opin Oncol; 1992 Jun; 4(3):525-32. PubMed ID: 1379832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]